Interviews | Page 6

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses what happens to a pharmacy if it is found to be out of compliance with DEA regulations or federal statutes.
Liz Tiefenthaler, president of Pharm Fresh Media, talks about some ways that pharmacists can improve the image of their business among patients.
Mark Parkinson, CEO of the American Health Care Association, discusses how payment models in the post-acute care industry have changed over the past 5 years.
Todd Semla, MS, PharmD, BCPS, FCCP, AGSF, National PBM Clinical Pharmacy Program Manager at the US Department of Veterans Affairs, discusses how to updated 2015 AGS Beers Criteria reflects new warnings about opioid use.
Todd Semla, MS, PharmD, BCPS, FCCP, AGSF, of the Department of Veterans Affairs explains how the AGS 2015 Beers Criteria will affect pharmacists' practice.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares what kinds of vaccinations pharmacists should expect to offer to their patients who travel abroad.
Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how the Pharmacy Disaster Support Center is different from similar centers.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, discusses some flaws of e-prescribing.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to controlled substance prescriptions.
Latest Issues